Impact of an antimicrobial-impregnated gauze dressing on surgical site infections including methicillin-resistant Staphylococcus aureus infections

American Journal of Infection Control

Volumn 36, Issue 9, 2008, Pages 651-655

  Mueller, Shawn Westadt ^a   Krebsbach, Larry E ^a  

^a Bryan LGH Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLY(HEXAMETHYLENEBIGUANIDE);

ARTICLE; CONTROLLED STUDY; GAUZE DRESSING; HEALTH CARE COST; HUMAN; INFECTION PREVENTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OUTCOME ASSESSMENT; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION; SURGICAL TECHNIQUE;

BANDAGES; BIGUANIDES; CROSS INFECTION; DISINFECTANTS; HUMANS; LENGTH OF STAY; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PREVALENCE; STAPHYLOCOCCAL INFECTIONS; SURGICAL WOUND INFECTION;

EID: 55049134155     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2007.12.005     Document Type: Article

References (16)

1. Bratzler D.W., and Hunt D.R. The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis 43 (2006) 322-330
2. Mangram A.J., Horan T.C., Pearson M.L., et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Am J Infect Control 27 (1999) 97-134
3. Cheadle W.G. Risk factors for surgical site infection. Surg Infect 7 (2006) S7-S11
4. Kirkland K.B., Briggs J.P., Trivette S.L., Wilkinson W.E., and Sexton D.J. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Epidemiol 20 (1999) 725-730
5. Dimick J.B., Chen S.L., Taheri P.A., Henderson W.G., Khuri S.F., and Campbell D.A. Hospital costs associated with surgical complications: a report from the private-sector national surgical quality improvement program. J Am Coll Surg 199 (2004) 531-537
6. Cosgrove S.E. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 42 (2006) S82-S89
7. Engemann J.J., Carmeli Y., Cosgrove S.E., Fowler V.G., Bronstein M.Z., and Trivette S.L. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphyloccus aureus surgical site infection. Clin Infect Dis 36 (2003) 592-598
8. Jernigan J.A. Is the burden of Staphylococcus aureus among patients with surgical site infections growing?. Infect Control Hosp Epidemiol 25 (2004) 457-460
9. Surgical Infection Prevention homepage. Available from: http://www.medqic.org/sipp. Accessed July 10, 2007.
10. Institutes for Healthcare Improvement homepage. Available from: http://ihi.org. Accessed July 10, 2007.
11. Anaya D.A., and Dellinger E.P. Challenges in the prevention of surgical site infections. Infect Med 23 (2006) 120-126
12. Available from: http://www.kendallamd.com/ProductInformation-HowItWorks.php. Accessed September 7, 2007.
13. Stone P.W., Larson E., and Kawar L.N. A systematic audit of economic evidence linking nosocomial infections and infection control interventions, 1990-2000. Am J Infect Control 30 (2002) 145-152
14. 3M DuraPrep Sugical Solution: Patient preoperative skin preparation, safety and efficacy data. Available from: www.3m.com/healthcare. Accessed September 7, 2007.
15. 3M One-Step Patient Prep: Patient preoperative skin preparation, safety and efficacy data. Available from: http://www.3m.com/healthcare. Accessed September 7, 2007.
16. Cardinal Scrub Care PVP-I Solution: In vivo efficacy study: Available from: www.cardinal.com/us/en/solutions/prep/index.aspAccessed September 7, 2007.